In the North American external defibrillator market, treatment algorithms and standard of care are shaping device features with increased survivability for the patient as topmost priority. The American Heart Association has collaborated with top manufacturers to devise treatment algorithms for patients with sudden cardiac arrest and other heart-related issues. Over the next few years, the cardiac catheterization lab will get closer and closer to the patient. Treatment will start at the actual scene of the event, instead of waiting until the patient arrives at the emergency department and is wheeled directly to the cardiac catheterization lab.
New analysis from Frost & Sullivan (patientmonitoring.frost.com) North American External Defibrillator Market finds that the market earned revenues of more than $547.4 million in 2010 and estimates this to reach $803.9 million in 2016. The research covers manual external defibrillators (MED) and automated external defibrillators (AED).
If you are interested in more information on this research, please send an email to Britni Myers, Corporate Communications, at britni.myers[.]frost.com, with your full name, company name, title, telephone number, company email address, company Website, city, state and country.
"Device features and integration of technology are helping to drive devices and average selling price," said Frost & Sullivan Industry Analyst Gary Burk. "Across the MED and AED segments of the market, technology is helping to shape and drive the future of the external defibrillator market."
Manual and automated external defibrillators are coming to market with features that help expedite patient care. Users of both types of devices are now able to receive direct feedback on the quality of care. In addition to immediate feedback, the devices are now programmed with cutting-edge treatment algorithms to improve survivability rates and have a significant impact on the effectiveness of the resuscitation.
Both MED and AED share common features. As technology automates treatment protocols, which are driven by new treatment algorithms, these devices will become less dependent upon the users' qualifications and skill level.
Though the economic crisis of 2009 heavily affected the North American external defibrillator market, it has been more resilient than others. Public companies in this space started displaying stronger performances over several quarters in 2010. Although the total number of external defibrillators declined in 2009 from previous years, overall profitability remained good.
"However, budget constraints over the past two years have controlled discretionary purchases for most end-users and directly impacted their purchasing and spending habits," said Burk. "Although purchasers have modified business models to offset some of these impacts, this has led to prolonged replacement cycles for some."
The North American market is heavily saturated and highly competitive with approximately seven competitors collectively offering more than 32 products in North America. The top three manufacturers in the external defibrillator market control approximately 85 percent of the market.
All newcomers to this market face a daunting task of competing with well-entrenched, large medical companies with a global presence. In this scenario, price, features, brand recognition, reliability, ease-of-use, and customer service are the major competitive factors that will contribute to successful business outcomes.
North American External Defibrillator Market is part of the Patient Monitoring Growth Partnership Service program, which also includes research in the following markets: North American Personal Emergency Response Systems Market, North American Cardiac Monitoring Services Market Outlook, and North American Cardiac Monitoring Product Market Outlook, among others. All research services included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.
About Frost & Sullivan
Frost & Sullivan (frost.com), the Growth Partnership Company, enables clients to accelerate growth and achieve best-in-class positions in growth, innovation and leadership. The company's Growth Partnership Service provides the CEO and the CEO's Growth Team with disciplined research and best-practice models to drive the generation, evaluation, and implementation of powerful growth strategies. Frost & Sullivan leverages 50 years of experience in partnering with Global 1000 companies, emerging businesses and the investment community from more than 40 offices on six continents.
North American External Defibrillator Market / N78E